Helping people with HIV quit smoking and improve their treatment outcomes
Official title: Patient-Oriented Substance Use/Smoking Cessation Research in HIV Treatment and Prevention
Funded at Massachusetts General Hospital · NIH-11085607 · Data updated 2026-11-12
This study is all about helping new researchers create better ways for people living with HIV to quit smoking, while also looking at how smoking affects their treatment, so that everyone can get the best care possible.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 30, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $212,818 |
| NIH project number | 1K24DA062568-01 |
| Project ID | NIH-11085607 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living with HIV who smoke and are seeking help to quit smoking.
✕Less likely to help
Patients who do not smoke or are not living with HIV may not receive any benefit from this research.
What this research studies
This research focuses on mentoring junior researchers to develop effective smoking cessation programs specifically for individuals living with HIV. It aims to understand how substance use impacts HIV treatment and outcomes, and to create integrated treatment approaches that enhance adherence to antiretroviral therapy. By emphasizing implementation science, the project seeks to ensure that new smoking cessation strategies are effectively applied in real-world settings, ultimately benefiting patients. The mentorship will also involve training on the development of tailored interventions for sub-populations of smokers with HIV.
Why it matters
Potential benefit: If successful, this research could lead to improved smoking cessation rates and better health outcomes for individuals living with HIV.
How similar studies have gone: Previous research has shown promising results in integrating substance use treatment with HIV care, indicating that this approach could be effective.
Where this research is happening
-
Massachusetts General Hospital
Boston, United States Active
Researchers
- Principal investigator: O'cleirigh, Conall Michael — Massachusetts General Hospital
- Study coordinator: O'cleirigh, Conall Michael
Related research
Other NIH-funded projects on the same topics.
-
Social stress and smoking: why disadvantaged young adults struggle to quit
This grant looks at how daily social stress affects if and when disadvantaged young adults who smoke can quit and stay quit.
-
I-STOP: a mobile health program to help people with HIV quit smoking
A smartphone-based program designed to help people with HIV quit smoking in a sustainable, affordable way.
-
Smoking cessation help for people with HIV in South Africa
A program is being tested to help people living with HIV in South Africa quit smoking in ways that fit low-resource clinics and show good value.
-
Mobile tools to understand how sleep affects quitting smoking
This project uses a smartphone to track sleep and smoking in lower-income adults trying to quit to find how sleep patterns relate to staying smoke-free.
-
Integrated approach to lung screening and quitting for African Americans
A multi-level program aims to boost LDCT lung cancer screening uptake and help African American smokers quit, with support from a comprehensive community-focused plan.
-
Peer-led smoking-cessation program for public housing residents
A peer-led program with eight group sessions plus nicotine replacement therapy is tested on adults living in public housing to help them quit smoking.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.